Viewing nowGlimedi Tablet 4mg (Glimepiride)
Glimepiride 4mg
Tablet · Prescription medication
Intro Biopharma Co., Ltd.

MFDS item code 201906632 · Approved 2019.09.23
Improvement of blood glucose control in type 2 diabetes
This medication is used to assist in controlling blood sugar levels in patients with type 2 diabetes. It can be administered alone alongside diet and exercise therapy, and if blood sugar control is insufficient, it may be combined with other hypoglycemic agents or insulin. It can especially be used in combination with metformin in cases where treatment with sulfonylureas or metformin alone is inadequate. This helps improve the patient's blood sugar control status.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. This drug should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses greater than 4 mg provide little additional benefit, but some patients have achieved better metabolic control with increases to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral antidiabetic drug to this drug There is no exact dose equivalence between this drug and other oral antidiabetic drugs. When switching from another oral antidiabetic drug to this drug, it is recommended to follow the method described under Initial Dose. That is, initiate treatment with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previous medication should be taken into consideration. 4) Dose adjustment during treatment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur after initial successful management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and initiate insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dose adjustment is required periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug and metformin are used in combination, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this drug is administered concomitantly with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients who have insulin-dependent diabetes, diabetic ketoacidosis, or are in a comatose state. Patients who have had allergic reactions to this medication, its components, or similar classes of drugs should also not receive it. There is no experience using this medication in patients with severely impaired liver or kidney function; in such cases, transitioning to insulin therapy is recommended. Women who are pregnant or potentially pregnant and breastfeeding mothers should not use this medication. Patients with severe infections, those undergoing surgery, or those with severe trauma may require insulin therapy. Patients with diarrhea or vomiting that prevents proper absorption of food are at risk of hypoglycemia and should be cautious. This medication contains lactose and should not be administered to patients with genetic disorders related to lactose. During the first week of dosing, the risk of hypoglycemia is high, so blood sugar levels should be monitored particularly carefully. Elderly patients, those with poor nutritional status, irregular eating habits, those who consume alcohol frequently, and patients with weak liver or kidney function are more vulnerable to hypoglycemia. Additionally, patients with other endocrine disorders or those taking multiple medications may also face an increased risk of hypoglycemia. Patients must inform medical professionals about hypoglycemic symptoms and risk factors and may require dosage adjustments if necessary. This medication effectively lowers blood sugar levels, and hypoglycemic symptoms may occur. Symptoms of hypoglycemia include headache, severe hunger, nausea, fatigue, anxiety, confusion, dizziness, drowsiness, and in severe cases, loss of consciousness or coma. If hypoglycemia occurs, it is essential to quickly raise blood sugar by consuming sugar, and it is advisable to always have sugar or sugary drinks available for consumption. Additionally, during the early stages of taking this medication, blurred vision, gastrointestinal disorders, liver function abnormalities, blood disorders, and allergic reactions may occur, so patients should consult a doctor immediately if any unusual symptoms appear. When taking this medication, regular meals, exercise, and weight management are important, and blood sugar control status should be checked regularly. In particular, during high stress, infections, or surgeries, blood sugar control may become difficult, so consultation with medical professionals is necessary. This medication requires dosage adjustments when administered to elderly patients with impaired kidney function. When taking this medication alongside other drugs, blood sugar control may be affected, so all current medications must be reported to healthcare providers. Some medications may increase or decrease the effects of this medication, particularly beta-blockers, antibiotics, anticoagulants, and corticosteroids may interact. In cases of overdose, there may be severe hypoglycemia necessitating immediate emergency treatment, and appropriate treatment should be followed as per the physician's instructions. This medication has not been proven safe and effective for children, so it should not be used in patients under 18 years of age. Medication should be stored out of reach of children and kept in the original container; changing the container arbitrarily is not allowed.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein issues, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increase in liver enzymes, liver dysfunction, biliary secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, granulocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, cutaneous photosensitivity, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial edema, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help safely maintain the medication's effectiveness.
Light blue rectangular tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 4mg
Tablet · Prescription medication
Intro Biopharma Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.